Search the web
Welcome, Guest
[Sign Out, My Account]

Saturday, March 28 2015 5:28am ET - U.S. Markets Closed.
Industry Center
Industry Center > > Aptalis Pharma Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
Aptalis Pharma Inc. Company Profile
Aptalis Pharma knows its ABCs when it comes to treating CF and GI ailments. The company develops and sells drugs mainly to treat cystic fibrosis (CF) and gastrointestinal (GI) conditions. Its Urso line treats liver disease; Carafate and Sulcrate treat ulcers; and Canasa and Salofalk offer relief for inflammatory bowel diseases. In addition, Aptalis Pharma markets Zenpep and other digestive drugs for patients with exocrine pancreatic insufficiency, a condition associated with CF. The firm's products are primarily sold in North America and the European Union. Aptalis Pharma was a subsidiary of Axcan Holdings, which is controlled by TPG Capital, but it was acquired by Forest Labs in 2014.
Contact Information
Address: 22 Inverness Center Pkwy., Ste. 310
Birmingham, AL 35242
Financial Highlights
Fiscal Year End:September
Key People
President and CEO: Frank Verwiel
SVP, CFO, and Treasurer: Steven R. (Steve) Gannon
SVP and Chief Corporate Development Officer: Theresa M. Stevens
Industry Information
Top Competitors
Lumara Health Inc.
Salix Pharmaceuticals, Ltd. (slxp)

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?